Aortic Dissection and Malperfusion: A practical guide to tame the beast!
Search
Displaying 621 - 640 of 1554
EEG in the Perioperative Period: Known knowns, known unknowns
Image-guided therapy: An emerging paradigm
We will present PRESS (Platelet Reactivity ExpreSsion Score), an integrative platelet reactivity score to identify those with a hyperreactive platelet phenotype, stratify cardiovascular risk, and uncover novel targets for atherothrombotic therapy development.
PCI versus CABG: The Ongoing Feud
Optimizing the Approach to Cardiovascular Genetics: Clinical, Translational and Teams
Home-grown Solutions for Cardiac Surgery in Africa: Meeting the needs of many
Perioperative Benzodiazepines: Should we use them in our patients?
Pre-emptive TAVI for Moderate Aortic Stenosis: Current status after TAVR unload
The Emerging Field of CardioObstetrics: What the Cardiologist Needs to Know
Dissecting Human Atherosclerosis with Multi-omics
2026 Spring Lecture Series
Spatially Mapping Atherosclerosis: Connecting Molecular Architecture to Clinical Understanding
Topic to be confirmed.
Dr. Martin Green is a Cardiologist at the University of Ottawa Heart Institute and Professor in the Department of Medicine at the University of Ottawa. His main interest is heart rhythm.
Marc-André Groulx is an Elected Director of the Ottawa Heart Institute Research Corporation(OHIRC) Board of Directors.
It was a cold, wintery morning on January 15 when a crowd of well-wishers joined numerous city and provincial dignitaries to celebrate the groundbreaking for the University of Ottawa Heart Institute’s expansion project. Many years in the making, the expansion will have a substantial impact on the...
Researchers at the Heart Institute say a diverse array of tools can help people quit e-cigarettes
Alexa Grudzinski, MD, is a cardiac anesthesiologist at the University of Ottawa Heart Institute and an assistant professor in the Faculty of Medicine at the University of Ottawa.
The Guideline-Directed Medical Therapy Clinic is a nurse-led clinic to help patients gradually increase the dosage of their heart failure medication to the target dosing. Heart failure medication has been proven to lower a patient’s risk of hospitalization and death when they have heart failure with reduced ejection fraction.